全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

eb病毒潜伏膜蛋白1基因多态性与nk/t细胞淋巴瘤的相关性

Keywords: eb病毒,淋巴瘤,结外nk/t细胞,潜伏膜蛋白1,基因多态性

Full-Text   Cite this paper   Add to My Lib

Abstract:

?目的:探讨eb病毒(ebv)潜伏膜蛋白1(lmp1)基因变异与山东地区结外鼻型nk/t细胞淋巴瘤(enktl)的相关性。方法:采用巢式pcr和dna测序检测山东地区ebv阳性enktl组织(47例)和健康成年人咽漱液(70例)中lmp1全长序列,与ebv标准株及相关序列进行比对,绘制系统进化树,根据其特征性突变对基因变异进行分类,比较lmp1各变异类型在enktl和健康人群中分布的差异。结果:117例标本完成测序,共发现3种主要变异类型:china1、china2和med-,其在enktl中的检出率分别为85.1%、8.5%和4.3%,在健康人群中的检出率分别为65.7%、5.7%和21.4%,另有1例(2.1%)enktl和5例(7.2%)健康人群为不同亚型的重组病毒株,lmp1亚型在2种人群中的分布差异具有统计学意义(p=0.022)。lmp1n端xhoi位点缺失变异即xhoi(-)和c端30bp缺失即del-lmp1在enktl中的检出率(95.7%和85.1%)高于健康人群(74.3%和67.1%),差异均有统计学意义(p=0.003和p=0.029)。结论:山东地区enktl中lmp1以china1亚型、xhoi(-)和del-lmp1为主,带有3种变异型的ebv毒株可能与enktl的发生相关。

References

[1]  asanon,katos,nakamuras.epstein-barrvirus-associatednaturalkiller/t-celllymphomas[j].bestpractresclinhaematol,2013,26(1):15-21.
[2]  knechth,bergerc,rothenbergers,etal.theroleofepstein-barrvirusinneoplastictransformation[j].oncology,2001,60(4):289-302.
[3]  tsaosw,tsangcm,tokf,etal.theroleofepstein-barrvirusinepithelialmalignancies[j].jpathol,2015,235(2):323-333.
[4]  hulf,zabarovskyer,chenf,etal.isolationandsequencingoftheepstein-barrvirusbnlf-1gene(lmp1)fromachinesenasopharyngealcarcinoma[j].jgenvirol,1991,72(sup10):2399-2409.
[5]  kingmadw,weisswb,jaffees,etal.epstein-barrviruslatentmembraneprotein-1oncogenedeletions:correlationswithmalignancyinepstein-barrvirus-associatedlympho-proliferativedisordersandmalignantlymphomas[j].blood,1996,88(1):242-251.
[6]  guirettidm,chabaypa,valvap,etal.structuralvariabilityofthecarboxy-terminusofepstein-barrvirusencodedlatentmembraneprotein1geneinhodgkin'slymphomas[j].jmedvirol,2007,79(11):1722-1730.
[7]  edwardsrh,sitki-greend,mooredt,etal.potentialselectionoflmp1variantsinnasopharyngealcarcinoma[j].jvirol,2004,78(2):868-881.
[8]  saechanv,moria,mitarnunw,etal.analysisoflmp1variantsofebvinsouthernthailand:evidenceforstrain-associatedt-celltropismandpathogenicity[j].jclinvirol,2006,36(2):119-125.
[9]  knechth,bachmanne,broussetp,etal.mutationalhotspotswithinthecarboxyterminalregionofthelmp1oncogeneofepstein-barrvirusarefrequentinlymphoproliferativedisorders[j].oncogene,1995,10(3):523-528.
[10]  zhouxg,sandvejk,lipj,etal.epstein-barrvirusgenepolymorphismsinchinesehodgkin'sdiseasecasesandhealthydonors:identificationofthreedistinctvirusvariants[j].jgenvirol,2001,82(5):1157-1167.
[11]  khanimf,yaoqy,niedobitekg,etal.analysisofepstein-barrvirusgenepolymorphismsinnormaldonorsandinvirus-associatedtumorsfromdifferentgeographiclocations[j].blood,1996,88(9):3491-3501.
[12]  zhangxs,songkh,maihq,etal.the30-bpdeletionvariant:apolymorphismoflatentmembraneprotein1prevalentinendemicandnon-endemicareasofnasopharyngealcarcinomasinchina[j].cancerlett,2002,176(1):65-73.
[13]  edwardsrh,seillier-moiseiwitschf,raab-traubn.signatureaminoacidchangesinlatentmembraneprotein1distinguishepstein-barrvirusstrains[j].virology,1999,261(1):79-95.
[14]  王云.ebv相关肿瘤中病毒基因多态性研究[d].青岛:青岛大学医学院,2010.
[15]  赵莎,刘卫平,王晓凌,等.结外鼻型nk/t细胞淋巴瘤中eb病毒潜伏膜蛋白1基因30bp碱基缺失的检测意义及与预后的关系[j].中华病理学杂志,2005,34(11):720-723.
[16]  kuott,shihly,tsangnm.nasalnk/tcelllymphomaintaiwan:aclinicopathologicstudyof22cases,withanalysisofhistologicsubtypes,epstein-barrviruslmp-1geneassociation,andtreatmentmodalities[j].intjsurgpathol,2004,12(4):375-387.
[17]  kimje,kimya,jeonyk,etal.comparativeanalysisofnk/t-celllymphomaandperipheralt-celllymphomainkorea:clinicopathologicalcorrelationsandanalysisofebvstraintypeand30-bpdeletionvariantlmp1[j].patholint,2003,53(11):735-743.
[18]  taiyc,kimlh,pehsc.highfrequencyofebvassociationand30-bpdeletioninthelmp-1geneincd56lymphomasoftheupperaerodigestivetract[j].patholint,2004,54(3):158-166.
[19]  millerwe,edwardsrh,wallingdm,etal.sequencevariationintheepstein-barrviruslatentmembraneprotein1[j].jgenvirol,1994,75(sup10):2729-2740.
[20]  nagaminem,takaharam,kishibek,etal.sequencevariationsofepstein-barrviruslmp1geneinnasalnk/t-celllymphoma[j].virusgenes,2007,34(1):47-54.
[21]  chiangak,wongky,liangac,etal.comparativeanalysisofepstein-barrvirusgenepolymorphismsinnasalt/nk-celllymphomasandnormalnasaltissues:implicationsonvirusstrainselectioninmalignancy[j].intjcancer,1999,80(3):356-364.
[22]  huangyh,wuql,zongys,etal.nasopharyngealextranodalnk/t-celllymphoma,nasaltype:retrospectivestudyof18consecutivecasesinguangzhou,china[j].intjsurgpathol,2011,19(1):51-61.
[23]  cabrerame,eizuruy,itoht,etal.nasalnaturalkiller/t-celllymphomaanditsassociationwithtype"i"/xhoilossstrainepstein-barrvirusinchile[j].jclinpathol,2007,60(6):656-660.
[24]  changcm,yukj,mbulaiteyesm,etal.theextentofgeneticdiversityofepstein-barrvirusanditsgeographicanddiseasepatterns:aneedforreappraisal[j].virusres,2009,143(2):209-221.
[25]  loak,huangdp,lokw,etal.phenotypicalterationsinducedbythehongkong-prevalentepstein-barrvirus-encodedlmp1variant(2117-lmp1)innasopharyngealepithelialcells[j].intjcancer,2004,109(6):919-925.
[26]  blakesm,eliopoulosag,dawsoncw,etal.thetransmembranedomainsoftheebv-encodedlatentmembraneprotein1(lmp1)variantcaoregulateenhancedsignallingactivity[j].virology,2001,282(2):278-287.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133